Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tong Mai Yang Xin Pill for stable coronary heart disease angina with myocardial injury
ChiCTR-IPR-14005714Phase 4Recruiting
- Sponsor
- Institute of Basic Theory for Chinese Medicine
- Start
- Aug 2013
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongmai Yangxin Pills in coronary arteriosclerosis and stable angina (2 arms), sponsored by Institute of Basic Theory for Chinese Medicine. Primary endpoints: BNP and high-sensitivity troponin absolute values, Ejection fraction and E/A ratio and 3 more. Started Aug 2013; status: recruiting.
02
Drugs
Tongmai Yangxin Pills
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR-IPR-14005714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005714.